A Healthier Approach:
The business case for IGA in the pharmaceutical sector
Because the pharmaceutical industry is so fast-paced, organisations face a difficult balancing act between agility and security when it comes to their approach to Identity and Access Management (IAM).
Read now
We will always keep your information safe. We ask for the information contained in this form in exchange for a valuable resource. By sharing your information it will also ensure we are able to send you educational information in future that we think will be of real value to you. We will never send you information about our products and services by email, unless it has been specifically requested.
*We respect your privacy and personal data. By submitting your details and downloading our document you are accepting Turnkey Consulting's privacy policy which can be found here.
Meet your hosts
However, pharmaceutical companies’ data is highly prized by cybercriminals, with hacking incidents targeting healthcare rising by 44% in the past year. In an industry where reputation and trust are paramount, an error-prone, manual approach to IAM is no longer fit for purpose.
In this guide, we partnered with SailPoint to outline how Identity Governance and Administration (IGA), an automated and centralised approach to IAM, can help pharmaceutical companies avoid the pitfalls of traditional methods and move towards more efficient and secure operations.
Specifically, we explore:
- Why both agility and security are critical in the pharmaceutical sector
- How digital innovation is widening the threat landscape
- The risks of ineffective identity management for pharma companies
- An introduction to IGA and the benefits it provides
In collaboration with: